Uh-oh. Comey is in trouble. OOPS !!
Top 10 Most Recent News Articles
InsCorp's Steady Q3 Climb Mirrors Strategic Focus
Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...
Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances
Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...
Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living
A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...
Continue Reading
CMRE Facing Legal Heat Over Wage Allegations
Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...
Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ
Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...
Continue Reading
Bybit Unveils Platform Vision at HK FinTech Week
Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...
Continue Reading
WHI's Nexus AI Transforms Phone Ordering in Parts Biz
Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...
Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf
Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...
Continue Reading
California Housing Affordability Stagnant as Rates Rise
Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...
Continue Reading
Endava's Securities Class Action Heats Up Wall Street
A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...
Continue ReadingTop 5 Most Recently Viewed Articles
Amendments Approved by Baltic Horizon Fund Bondholders
Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...
Continue Reading
Sagimet Biosciences Shares Exciting First Quarter Highlights
Sagimet Biosciences Financial Overview Sagimet Biosciences Inc. (NASDAQ: SGMT), a pioneering clinical-stage biopharmaceutical company, has made waves in the healthcare industry with its innovative approach to combating metabolic dysfunction and fibrotic diseases. Recently, this California-based firm announced their financial results for the first quarter, concluding on...
Continue Reading
Important Class Action for Lilium N.V. Shareholders to Join
Class Action Notice for Shareholders of Lilium N.V. (LILMF) The Gross Law Firm has announced a significant action that involves shareholders of Lilium N.V. (LILMF). This notice is particularly important for those who have purchased shares during the specified class period. If you have invested in Lilium, it is crucial to understand the implications of this class action....
Continue Reading
Intellia Launches Pivotal Phase 3 Trial for NTLA-2002
Intellia Therapeutics Advances Gene Editing with NTLA-2002 Intellia Therapeutics, Inc. (NASDAQ: NTLA), an innovator in CRISPR-based gene editing therapies, has announced the launch of a pivotal Phase 3 trial for its revolutionary treatment NTLA-2002. This therapy is aimed at addressing hereditary angioedema (HAE), a rare but severe condition that can lead to...
Continue Reading
Margot Black Unveils New Book: Transform Your Dreams Now
Margot Black Announces Her Empowering New Book Margot Black's latest guide offers a roadmap for dreamers to achieve real-life results Award-winning publicist, communication strategist, and bestselling author Margot Black is set to inspire readers with her third book, How to Be Your Own Fairy Godmother and Make Your Life Come True. This innovative guide is crafted to...
Continue Reading